We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 49

Schering v. Pharmascience, merits of NOC proceeding

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 20 2010

The application under the NOC Regulations was dismissed

Sanofi v. Hospira, merits of a 55.2 proceeding

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 3 2009

The Court refused to grant an Order of Prohibition against Hospira regarding its docetaxel product

Pfizer v. ratiopharm, motion to amended a previous judgment on the merits

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 3 2009

ratiopharm was successful in the proceeding under the NOC Regulations at the trial level, but the decision was overturned on appeal

Bayer Inc. v. Canada (Health), listing decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 3 2009

The Court dismissed a judicial review of the Minister’s decision refusing to list a formulation patent on the Patent Register

Pfizer v. ratiopharm, motion to intervene in appeal of infringement proceedings

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 3 2009

The Court of Appeal denied BIOTEC Canada’s and Eli Lilly’s leave to intervene in Pfizer’s appeal of the Court’s decision to invalidate a patent for amlodipine

Pfizer v. ratiopharm Inc.; interlocutory motion on appeal of impeachment decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 3 2009

Pfizer filed a motion to amend the contents of its appeal book, its notice of appeal and its memorandum of fact and law on the appeal to deal with the additional grounds

Eli Lilly Canada Inc. v. Apotex; application to declare NOA null and void

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

Apotex sent a NOA regarding the validity of a patent list on the Patent Register for an orally disintegrating tablet form of a drug

Sanofi-Aventis v. Novopharm; preliminary questions regarding costs assessment

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

Sanofi had brought a proceeding against Novopharm and joined Schering as the respondentpatentee pursuant to the NOC Regulations

Sanofi-Aventis v. Canada; PMPRB decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

Sanofi was seeking judicial review of an interlocutory decision of the Board, which was made during the course of dealings that had lasted a number of years

Apotex & Novopharm v. Wellcome; interlocutory motion to amend pleadings

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

The Trial Division upheld the decision of the Prothonotary to allow GSK to amend its pleadings revising the quantum of damages sought in the proceeding